Abstract
Purpose: The purpose of this study is to measure in vivo linear head penetration of a newer generation highly crosslinked liner (X3, Stryker Orthopedics) using Radiostereometric Analysis (RSA).
Method: The 12 hips (11 patients) included in this study are a subset from a larger randomized controlled trial comparing Exeter stem migration in cement mantles with and without Tobramycin. Criteria for inclusion in this subset were the use of an uncemented Trident acetabular component containing X3 polyethylene in combination with a 32 mm stainless steel femoral head. The average age was 72.7 years (range 65 to 80), and there was an equal gender distribution. RSA examinations were taken with patients lying supine at six weeks, six months, one year, and two years postoperatively. The six week examinations were used as the reference examinations for measuring head penetration. Radiographic measurements and analyses were performed with the UmRSA software suite version 6.0 (RSA Biomedical, Umea, Sweden). Head penetration was determined via edge-detection measurements of the femoral head and acetabular cup.
Results: The mean cumulative femoral head penetration at 6 months was 0.23 mm; this remained statistically unchanged both at 1 year: 0.20mm (p=0.69, 95% UCL of the difference: +0.15mm) and 2 years: 0.25mm (p=0.77, 95% UCL of the difference: +0.10mm).
Conclusion: It is generally recognized that femoral head penetration of more than 0.1 mm per year can result in osteolysis. The purpose of cross linking polyethylene is to reduce wear to below this level. The results of this study show that after an initial bedding in of approximately 0.2 mm, femoral head penetration is not detectable over the subsequent 18 months. Further follow-up is underway to confirm that this promising reduction in wear is maintained.
Correspondence should be addressed to: COA, 4150 Ste. Catherine St. West Suite 360, Westmount, QC H3Z 2Y5, Canada. Email: meetings@canorth.org
